I. Fernandes et al., NaPO4 cotransport type III (PiT1) expression in human embryonic kidney cells and regulation by PTH, AM J P-REN, 277(4), 1999, pp. F543-F551
The aim of the present study was to characterize the type(s) of NaPO4 cotra
nsporter expressed in the human renal cell line HEK-293 and its regulation
by parathyroid hormone (PTH) in wild-type cells and in cells transfected by
the PTH/PTH-related protein (PTHrP) receptor. The results showed that huma
n embryonic kidney HEK-293 cells expressed NaPO4 cotransporter type III (Pi
T1) mRNA and protein. In contrast, type I (NPT1) or II (NPT2) cotransporter
mRNA were not expressed. Nai-dependent phosphate uptake followed a Michael
is-Menten model (apparent maximal transport rate and affinity constant: 23.
32 +/- 0.69 nmol PO4.mg protein(-1).10 min(-1) and 0.147 +/- 0.014 mM KH2PO
4, respectively), was stimulated by phosphate deprivation (maximal increase
24.5 +/- 0.8%, P < 0.001, after 15 h of phosphate deprivation), and was in
hibited by increasing pH (3.6 +/- 0.2-fold decrease at pH 8.5, P < 0.0001).
It was inhibited in a time- and concentration-dependent fashion by PTH in
HEK-293 cells stably transfected by PTH/PTHrP receptors but not in parental
HEK-293 cells. Maximal inhibition of Na+-dependent phosphate transport was
observed at 30 min after the addition of 72 nM PTH-(1-34) (31.5 +/- 2.4% i
nhibition, P < 0.01). PTH inhibition of phosphate transport was maintained
in phosphate-deprived cells and reversed by both GF109203X (10(-6) M) or st
aurosporine (5.5 nM), two protein kinase C inhibitors. Na+-dependent phosph
ate uptake was also significantly inhibited by phorbol 12-myristate 13-acet
ate (20.9 +/- 3.9% inhibition, P < 0.001) but not by dibutyril-cAMP (10(-4)
M) or forskolin (50 mu M). The physiological role played by type III NaPO4
cotransport expression in the overall renal regulation of phosphate homeos
tasis remains to be established.